Merck & Co. is adding yet another immuno-oncology first under Keytruda’s belt. But the breadth of the win comes out less than ideal. The FDA has backed Keytruda’s use alongside chemotherapy, with or without Roche’s Avastin, for treating patients with persistent, recurrent or metastatic cervical cancer but only for those whose tumors express the PD-L1… Read More »
ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the… Read More »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »
An interdisciplinary group of scientists has successfully destroyed tumor cells in mice by using nano-sized copper compounds alongside immunotherapy. Importantly, the tumors did not return after the treatment ceased. According to the World Health Organization, cancer is the second leading cause of death worldwide — in 2018, it was responsible for approximately 9.6 million deaths.… Read More »
An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say. In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years – five times longer than under chemotherapy. The patients also suffered far fewer side-effects. Cases… Read More »
Food allergies are on the risePicture Partners/Alamy By Sam Wong For people with peanut allergies, undergoing immunotherapy may actually increase their risk of having allergic or anaphylactic reactions. Immunotherapy is an experimental treatment for allergies that involves repeated exposure to the allergen in gradually increasing doses, aiming to desensitise the patient’s immune system. To get… Read More »